| JDJRX | QGMNX | JDJRX / QGMNX | |
| Total Expense Ratio | 1.25 | 1.77 | 71% |
| Annual Report Gross Expense Ratio | 1.26 | 1.77 | 71% |
| Fund Existence | 7 years | 12 years | - |
| Gain YTD | 10.539 | 0.622 | 1,695% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 2500 | 40,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 910M | 1.03B | 88% |
| Annual Yield % from dividends | 0.39 | 1.20 | 33% |
| Returns for 1 year | 8.55 | 0.29 | 2,986% |
| Returns for 3 years | 1.23 | 2.80 | 44% |
| Returns for 5 years | 17.00 | 14.69 | 116% |
| Returns for 10 years | N/A | 22.99 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVII | 25.36 | 0.53 | +2.13% |
| REX NVDA Growth & Income ETF | |||
| KBWY | 17.97 | 0.19 | +1.08% |
| Invesco KBW Premium Yield Eq REIT ETF | |||
| XRMI | 17.33 | 0.02 | +0.12% |
| Global X S&P 500® Risk Managed Inc ETF | |||
| THNR | 24.26 | N/A | N/A |
| Amplify Weight Loss Drug & Treatment ETF | |||
| RPV | 112.87 | -0.49 | -0.43% |
| Invesco S&P 500® Pure Value ETF | |||